Eysz

Eysz, founded by pediatric neurologist Dr. Rachel Kuperman, is a breakthrough digital platform that makes diagnosing tricky neurological and psychiatric symptoms like inattention, staring, and cognitive challenges easier. Backed by NIH and NSF research, Eysz has launched its first FDA-registered product with validated reimbursement and clinical guidelines, leading to swift adoption. This tool empowers primary care physicians to drive earlier interventions and better patient outcomes